"Ovarian cancer" is a term often used to describe cancers that develop from the lining of the fallopian tubes, surface of the ovary, or lining of the pelvis or abdomen. Most often when people speak of "ovarian cancer," they are referring to one of the epithelial ovarian cancers, such as high-grade serous epithelial ovarian cancer, the most common ovarian cancer. Overall, however, there are many different types of cancer that can develop from the ovaries, fallopian tubes or lining of the pelvis or abdomen (peritoneal cancer). Distinctions beween the different types of ovarian cancer are very important because different ovarian cancers can have very different prognosis and treatment. Most postmenopausal or perimenopausal women with ovarian cancer have an epithelial ovarian cancer such as high-grade serous or mucinous carcinoma. Younger women with ovarian cancer may have an epithelial ovarian cancer, but also may have other types of rarer ovarian cancers such as granulosa cell tumor, dysgerminoma, malignant teratomas, among many others.
Among women with high-grade serous ovarian cancer, most are diagnosed at an advanced stage (stage III or IV) and their treatment will require a combination of chemotherapy and surgery to achive the best possible prognosis and outcome. Some women receive chemotherapy before surgery (neoadjuvant chemotherapy approach) while others have surgery before chemotheray (primary debulking approach), with that decision individualized for each woman.
Many women with ovarian cancer are also candidates for minimally invasive surgery, usually performed through small incisions as outpatient surgery. This includes women with large ovarian masses and/or advanced disease/metastasis. The outcomes of minimially invasive surgery for ovarian cancer are currently being studied in a large randomized controlled trial, with preliminary results showing a low rate of conversion to open (traditional large up-and-down incision) surgery when these procedures are performed by qualified surgeons. A national database study also showed that about 30% of ovarian cancers have already been treated with minimally invasive surgery in recent years, which is primarily the result of relatively few practicing Gynecologic Oncologists having surgical expertise and experience with performing ovarian cancer surgeries for advanced disease robotically. Dr. Seagle has been performing advanced minimally invasive Gynecologic and Gynecologic Oncology surgeries in South Georgia since 2018.
At Southland Uro+Gynecology, LLC, Dr. Seagle routinely evaluates and manages women with newly-diagnosed or suspected ovarian cancer. Most staging procedures are performed robotically as outpatient surgery. Care is individualized based on the needs of each woman and care is coordinated with each woman's local or preferred cancer center specialists, typically Medical Oncology. When rarely needed or in the best interest of the patient, procedures are coordinated with top-notch local Surgical Oncologists or patients are referred to academic centers for Gynecologic Oncology (Medical College of Georiga or Emory) depending on their trial eligibility and/or unusual circumstances. Most women can receive outstanding and individualized care for their ovarian cancer at home or closer to home in South Georgia.
Copyright © 2024 Southland Uro+Gynecology, LLC - All Rights Reserved.
Powered by GoDaddy
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.